Zymeworks Inc.ZYMENASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +83.33% | +170.29% | +153.21% | +72.59% | -91.90% |
| Gross Profit Growth | +83.33% | +170.29% | +153.21% | +72.59% | -97.34% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +7.08% | -1.37% | -1.38% | -0.47% | -0.67% |
| Weighted Average Shares Diluted Growth | +7.13% | -1.34% | +1.29% | -0.50% | -0.71% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -397.46% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -442.80% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +186.57% | -20.53% | -91.80% | +23.83% | -91.69% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -20.28% | -23.16% | -20.80% | -18.45% | -25.17% |
| Book Value per Share Growth | -31.94% | -24.78% | -16.49% | -12.37% | -20.21% |
| Debt Growth | -30.75% | -26.81% | -6.91% | -6.65% | -1.29% |
| R&D Expense Growth | +45.21% | +11.53% | +18.13% | -2.13% | -15.72% |
| SG&A Expenses Growth | +9.63% | +1316.67% | -5.10% | +1.44% | -15.18% |